Data Foundry

Drug recalls 2026

Exenatide Injection — Class II drug recall D-0868-2026

Ongoing recall by Amneal Pharmaceuticals of New York, LLC, reported 2026-09-30, distributed nationwide. Defective Delivery System: Possibility of no medication in the prefilled pen.

Recall numberD-0868-2026
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmAmneal Pharmaceuticals of New York, LLC, Brookhaven, NY, United States
Recall initiated2026-08-28
Classified2026-09-22
Reported by FDA2026-09-30
DistributedNationwide (US)
Quantity5,694 pens
NDC70121-1685, 70121-1685-01, 70121-1686, 70121-1686-01
Lot numbersAP250095A
Expiration dates2027-02-28

Product

Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1

Reason for recall

Defective Delivery System: Possibility of no medication in the prefilled pen.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0868-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-06. Not affiliated with or endorsed by FDA. Not medical or legal advice.